Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

21.08.2023

2 Antiviral Res
5 BMJ
4 Clin Infect Dis
2 Emerg Infect Dis
6 Int J Infect Dis
1 Intensive Care Med
2 J Infect
5 J Med Virol
1 J Travel Med
3 J Virol
4 JAMA
2 Lancet
2 Lancet Infect Dis
4 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
2 Nature


    Antiviral Res

  1. VANDERLINDEN E, Boonen A, Noppen S, Schoofs G, et al
    PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding.
    Antiviral Res. 2023;217:105700.
    >> Share

  2. CORONA A, Madia VN, De Santis R, Manelfi C, et al
    Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication.
    Antiviral Res. 2023;217:105697.
    >> Share


    BMJ

  3. IACOBUCCI G
    Covid-19: A year is too long to wait for UK inquiry's recommendations, say bereaved families.
    BMJ. 2023;382:1853.
    >> Share

  4. SIVAN M, Lawrence RR, Francis E
    Digital interactive patient reported outcome measures for long term conditions.
    BMJ. 2023;382:1816.
    >> Share

  5. PAGEL C
    Covid is on the rise again-so what next?
    BMJ. 2023;382:p1885.
    >> Share

  6. LANG K
    How do we best use Paxlovid and other covid antivirals?
    BMJ. 2023;382:p1666.
    >> Share

  7. DYER O
    Covid-19: Infections climb globally as EG.5 variant gains ground.
    BMJ. 2023;382:p1900.
    >> Share


    Clin Infect Dis

  8. LIANG TJ, Law JLM, Pietschmann T, Ray SC, et al
    Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model.
    Clin Infect Dis. 2023;77.
    >> Share

  9. GVINJILIA L, Baliashvili D, Shadaker S, Averhoff F, et al
    Impact of HCV infection and treatment on mortality in the country of Georgia, 2015-2020.
    Clin Infect Dis. 2023 Apr 26:ciad182. doi: 10.1093.
    >> Share

  10. JOFFE AR, Elliott A, Eapen R, Milburn C, et al
    Is vaccination acting as a placebo in preventing symptoms of Long-COVID?
    Clin Infect Dis. 2023 Apr 19:ciad234. doi: 10.1093.
    >> Share

  11. VAN EFFELTERRE T, Hens N, White LJ, Gravenstein S, et al
    Modeling Respiratory Syncytial Virus Adult Vaccination in the United States with a Dynamic Transmission Model.
    Clin Infect Dis. 2023 Mar 23:ciad161. doi: 10.1093.
    >> Share


    Emerg Infect Dis

  12. MOONAN PK, Smith JP, Borah BF, Vohra D, et al
    Home-Based Testing and COVID-19 Isolation Recommendations, United States.
    Emerg Infect Dis. 2023;29.
    >> Share

  13. ANDRONESCU LR, Richard SA, Laing ED, Pisanic N, et al
    Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population.
    Emerg Infect Dis. 2023;29.
    >> Share


    Int J Infect Dis

  14. MIDDELKOOP K, Stewart J, Walker N, Delport C, et al
    Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids).
    Int J Infect Dis. 2023;134:63-70.
    >> Share

  15. WAILI BA, Yazidi LA, Hashami HA, Gheilani MA, et al
    A comparative study of SARS-CoV-2 and common human coronavirus infections among children presenting to tertiary care in Oman.
    Int J Infect Dis. 2023 Aug 9:S1201-9712(23)00690.
    >> Share

  16. LOW EV, Pathmanathan MD, Chidambaram SK, Kim WR, et al
    Real world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk COVID-19 patients during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort study.
    Int J Infect Dis. 2023 Aug 9:S1201-9712(23)00688.
    >> Share

  17. CHAE C, Kim RK, Jang EJ, Shim JA, et al
    Comparing the Effectiveness of Bivalent and Monovalent COVID-19 Vaccines against COVID-19 Infection during the Winter Season of 2022-2023: A Real-World Retrospective Observational Matched Cohort Study in the Republic of Korea.
    Int J Infect Dis. 2023 Aug 10:S1201-9712(23)00695.
    >> Share

  18. EDELSTEIN M, Beiruti KW, Ben-Amram H, Beer N, et al
    Vaccine-induced and hybrid immunity to SARS-CoV-2 after three or four doses of BNT162b2 - results from 22 months follow-up of a healthcare workers cohort, Israel, 2020-2022.
    Int J Infect Dis. 2023 Aug 10:S1201-9712(23)00694.
    >> Share

  19. JANHA RE, Bah A, Jah H, Touray F, et al
    SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
    Int J Infect Dis. 2023 Aug 14:S1201-9712(23)00697.
    >> Share


    Intensive Care Med

  20. SHEPHERD JM, Ross J, Anton L, Rourke C, et al
    Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial.
    Intensive Care Med. 2023;49:922-933.
    >> Share


    J Infect

  21. WHITAKER HJ, Tsang RS, Byford R, Aspden C, et al
    COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.
    J Infect. 2023 Aug 12:S0163-4453(23)00456-5. doi: 10.1016/j.jinf.2023.
    >> Share

  22. WAGENHAUSER I, Mees J, Reusch J, Lam TT, et al
    Determinants of Influenza A Infection Rate in Post-COVID-19 Era.
    J Infect. 2023 Aug 9:S0163-4453(23)00455-3. doi: 10.1016/j.jinf.2023.
    >> Share


    J Med Virol

  23. SUN Z, Wang S, Sun X, Shi Y, et al
    COVID-19 has causal effects on cancer risk? Something we might ignore.
    J Med Virol. 2023;95:e29034.
    >> Share

  24. BAUER C, Mack E, Hefter V, Fischer A, et al
    Impaired systemic nucleocapsid antigen clearance in severe COVID-19.
    J Med Virol. 2023;95:e29032.
    >> Share

  25. MAK WA, Visser W, van der Vliet M, Markus HY, et al
    Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals.
    J Med Virol. 2023;95:e28989.
    >> Share

  26. DAS A, Meng W, Liu Z, Hasib MM, et al
    Molecular and immune signatures, and pathological trajectories of fatal COVID-19 lungs defined by in situ spatial single-cell transcriptome analysis.
    J Med Virol. 2023;95:e29009.
    >> Share

  27. LU S, Luo S, Bai B, Fan Z, et al
    Omicron breakthrough infections in wild-type SARS-CoV-2 vaccinees elicit high levels of neutralizing antibodies against pangolin coronavirus GX_P2V.
    J Med Virol. 2023;95:e29031.
    >> Share


    J Travel Med

  28. ZHANG Y, Liu Y, Gao Y, Man S, et al
    An alarming rise in COVID-19-related acute macular Neuroretinopathy in China: a cross-sectional multimodal imaging study.
    J Travel Med. 2023 Aug 10:taad109. doi: 10.1093.
    >> Share


    J Virol

  29. LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al
    A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
    J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597.
    >> Share

  30. JIN H, Cheng L, Gong Y, Zhu Y, et al
    Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
    J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192.
    >> Share

  31. ZHANG W, Shi K, Geng Q, Herbst M, et al
    Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
    J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822.
    >> Share


    JAMA

  32. RAGLOW Z, Malani PN, Petty LA
    Outpatient Treatment for COVID-19.
    JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.16666.
    >> Share

  33. RUBIN R
    Why Blood Type Seems to Be Linked With COVID-19 Risk.
    JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.15996.
    >> Share

  34. DOS SANTOS RAS, Taccone FS, Annoni F
    Renin-Angiotensin System Modulation in Adults With COVID-19.
    JAMA. 2023;330:663-664.
    >> Share

  35. SELF WH, DeClercq J, Orr M
    Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
    JAMA. 2023;330:664-665.
    >> Share


    Lancet

  36. IFTEKHAR N, Sivan M
    Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
    Lancet. 2023;402:e9.
    >> Share

  37. KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al
    Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
    Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777.
    >> Share


    Lancet Infect Dis

  38. ABO YN, Jamrozik E, McCarthy JS, Roestenberg M, et al
    Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy.
    Lancet Infect Dis. 2023 Aug 10:S1473-3099(23)00294.
    >> Share

  39. GRANT R, Benamouzig D, Catton H, Cheng VC, et al
    COVID-19 pandemic: a catalyst for accelerating global action on patient safety.
    Lancet Infect Dis. 2023 Aug 9:S1473-3099(23)00485.
    >> Share


    MMWR Morb Mortal Wkly Rep

  40. MONTOY JCC, Ford J, Yu H, Gottlieb M, et al
    Prevalence of Symptoms
    MMWR Morb Mortal Wkly Rep. 2023;72:859-865.
    >> Share

  41. FORD ND, Slaughter D, Edwards D, Dalton A, et al
    Long COVID and Significant Activity Limitation Among Adults, by Age - United States, June 1-13, 2022, to June 7-19, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:866-870.
    >> Share

  42. NAVARRETE J, Barone G, Qureshi I, Woods A, et al
    SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves - United States, June 30, 2021-September 27, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:871-876.
    >> Share

  43. LINK-GELLES R, Ciesla AA, Rowley EAK, Klein NP, et al
    Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:886-892.
    >> Share


    N Engl J Med

  44. RUSSELL FM, Curtis N, Carlin J
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:578-579.
    >> Share

  45. LADHANI SN, Andrews N, Ramsay ME
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:579.
    >> Share

  46. MARINE JE
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:579.
    >> Share

  47. MURRAY EJ, Cowger TL, Hall KT
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff. Reply.
    N Engl J Med. 2023;389:580.
    >> Share


    Nature

  48. NUWER R
    Chinese students stay local as favour falls with study abroad.
    Nature. 2023;620:S11-S13.
    >> Share

  49. KOZLOV M
    Key alert system for disease outbreaks is in crisis - can it be saved?
    Nature. 2023;620:476-477.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016